Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysis.

Liu, Song et al.·Frontiers in endocrinology·2025·
RPEP-122392025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysis.
Published In:
Frontiers in endocrinology, 16, 1513641 (2025)
Database ID:
RPEP-12239

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-12239·https://rethinkpeptides.com/research/RPEP-12239

APA

Liu, Song; Hu, Jiaqiang; Zhao, Chen; Liu, Hang; He, Chunyang. (2025). Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysis.. Frontiers in endocrinology, 16, 1513641. https://doi.org/10.3389/fendo.2025.1513641

MLA

Liu, Song, et al. "Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysis.." Frontiers in endocrinology, 2025. https://doi.org/10.3389/fendo.2025.1513641

RethinkPeptides

RethinkPeptides Research Database. "Comparative efficacy of incretin drugs on glycemic control, ..." RPEP-12239. Retrieved from https://rethinkpeptides.com/research/liu-2025-comparative-efficacy-of-incretin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.